# Wearing-Off Period of Pharmacological Dilation and Anisocoria

> **NCT05238233** · PHASE4 · COMPLETED · sponsor: **Prisma Health-Upstate** · enrollment: 11 (actual)

## Conditions studied

- Anisocoria

## Interventions

- **DRUG:** Tropicamide
- **DRUG:** 1% Pilocarpine
- **DRUG:** Proparacaine Hydrochloride
- **DEVICE:** Tono pen AVIA
- **DEVICE:** VG4 Gonio
- **DEVICE:** Reichert phoropter

## Key facts

- **NCT ID:** NCT05238233
- **Lead sponsor:** Prisma Health-Upstate
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2023-01-17
- **Final completion:** 2023-01-17
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05238233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05238233, "Wearing-Off Period of Pharmacological Dilation and Anisocoria". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05238233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*